AXGN.NASDAQAxogen, INC

Form 4: Axogen CFO Lindsey Marie Hartley Reports Acquisition of 26,000 Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Axogen's CFO, Lindsey Marie Hartley, reported the acquisition of 26,000 restricted stock units in a recent SEC Form 4 filing.

Summary

  • Lindsey Marie Hartley, CFO of Axogen, Inc., filed a Form 4 with the SEC.
  • The filing reports a transaction on May 12, 2025, where Hartley acquired 26,000 restricted stock units (RSUs).
  • Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock.
  • The RSUs vest over four years, with 50% vesting on May 12, 2027, and an additional 25% vesting each 12 months thereafter, with full vesting on May 12, 2029.
  • Vested shares will be delivered to Hartley upon the vesting date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The RSU grant is a standard practice and indicates confidence in the company's future, but it doesn't represent a major event.

Positives

  • The grant of RSUs to the CFO aligns her interests with those of the shareholders, incentivizing her to improve the company's performance over the vesting period.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance, but the vesting schedule of the RSUs suggests a long-term commitment from the CFO.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

  • Executive compensation packages, including RSU grants, are common in publicly traded companies like Axogen.
  • Companies such as Integra LifeSciences and Stryker also utilize similar equity-based compensation to incentivize their executives.
  • The vesting schedule of four years is fairly standard within the industry, promoting long-term commitment and alignment with shareholder value.

Stakeholder Impact

  • Shareholders may view the RSU grant positively as it aligns management's interests with long-term shareholder value.
  • Employees may see the RSU grant as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/12/2025Date of transaction: Acquisition of 26,000 restricted stock units.
05/12/202750% of the restricted stock units vest.
05/12/202825% of the restricted stock units vest.
05/12/2029Remaining 25% of the restricted stock units vest; full vesting date.
05/16/2025Date of signature on the Form 4 filing.

Keywords

Axogen, Hartley, Restricted Stock Units, RSU, Form 4, SEC Filing, CFO, AXGN, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.